Schematische Darstellung der EGF-Rezeptoraktivierung durch EGF und Aktivierung der intrazellulären Signalkaskade.
Cetuximab: Blockade des EGF-Rezeptors durch Cetuximab
Cetuximab: weitgehende Abeheilung der Psoriasis nach 1-wöchiger Therapie mit Cetuximab. Abbildung entnommen aus: Okamoto K et al. (2015) Cetuximab and panitumumab in a patient with colon cancer and concomitant chronic skin disease: a potential beneficial effect on psoriasis vulgaris. World JGastroenterol 21:3746-3749.
Please login to access all articles, images, and functions.
Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).
Please complete your registration to access all articles and images.
To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.